These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35394713)

  • 1. [Neurological manifestations of postcovid syndrome].
    Kamchatnov PR; Cheremin RA; Skipetrova LA; Chugunov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):7-15. PubMed ID: 35394713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological Signs of Postcovid Syndrome.
    Kamchatnov PR; Cheremin RA; Skipetrova LA; Chugunov AV
    Neurosci Behav Physiol; 2022; 52(7):968-975. PubMed ID: 36589208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Neurosci Behav Physiol; 2022; 52(6):836-841. PubMed ID: 36311877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of the sequential use of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):59-64. PubMed ID: 32307432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Improvement of the efficacy of treatment of hypertensive encephalohathy by using mexidol].
    Bolotova EV; Lushpay NY; Kovrigina IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(4):61-64. PubMed ID: 29863694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
    Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of the efficacy and safety of Mexidol and Mexidol Forte 250 in patients with chronic cerebral ischemia].
    Kutashov VA; Ulyanova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(12. Vyp. 2):89-92. PubMed ID: 32207723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurological disorders in the postcovid period].
    Fedin AI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):31-37. PubMed ID: 36279226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
    Chukanova EI; Chukanova AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):39-45. PubMed ID: 31626217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities of improving the effectiveness of therapy in patients with chronic cerebral ischemia against the background of COVID-19].
    Kovalchuk VV; Ershova II; Molodovskaya NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(3. Vyp. 2):60-66. PubMed ID: 33908234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Improving the effectiveness of pharmacotherapy in comorbid patients with chronic cerebral ischemia on an outpatient basis].
    Vizilo TL; Arefieva EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3):51-55. PubMed ID: 36946397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The efficacy and safety of Mexidol Forte 250 as part of long-term sequential therapy in patients with carotid stroke].
    Strelnikova IA; Svetkina AA; Androfagina OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(3. Vyp. 2):54-58. PubMed ID: 32307431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurological aspects of the consequences of COVID-19 in children].
    Nemkova SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):23-30. PubMed ID: 35485061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
    Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
    Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of mexidol for transient ischemic attacks in the vertebrobasilar system in elderly patients with chronic cerebral ischemia].
    Abramenko YV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9. Vyp. 2):42-48. PubMed ID: 30499559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemia].
    Zhuravleva MV; Prokofiev AB; Serebrova SY; Vasyukova NS; Demchenkova EY; Arkhipov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):119-124. PubMed ID: 32678558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ; Zaharov YA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(5):23-27. PubMed ID: 27240176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy of mexidol in carotid endarterectomy procedure in patients with cerebral atherosclerotic stenosis].
    Golovkin VI; Svetlikov AV; Shapovalov AS; Popova LO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(1):51-55. PubMed ID: 26977626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neuroprotective therapy of outpatient treatment of chronic cerebral ischemia].
    Berezhnaya SV; Yakupov EZ
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):48-52. PubMed ID: 26356397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.